Quality-of-life improvements increased from 81% of patients reporting benefit at 12 to 18 months to more than 90% at 30 to 36 months, one of the clearest signals in the dataset that longer treatment ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of β-glucans. These are natural sugar compounds found in bacteria, fungi and ...

Early introduction of peanut protein reduces allergy prevalence by approximately 80%, with efficacy diminishing as introduction is delayed. Appropriate prevention involves ingestion of approximately 2 ...

Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

Peanut allergy treatments are improving. Options like oral immunotherapy and biologics are helping lower the risk of severe reactions if you’re exposed to peanuts. Living with a peanut allergy can be ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...